ArticleJournal of diabetes science and technology2019

Postmarket Surveillance of Blood Glucose Monitor Systems Is Needed for Safety of Subjects and Accurate Determination of Effectiveness in Clinical Trials of Diabetes Drugs and Devices.

David C KlonoffPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.